1![](https://www.pdfsearch.io/img/fcd38139b0a06229cf6ec3da59dfb625.jpg) | Add to Reading ListSource URL: www.goldcopd.orgLanguage: English |
---|
2![ADCIRCA® (tadalafil) NAME OF THE MEDICINE ADCIRCA® (tadalafil). Chemically, tadalafil is pyrazino[1’, 2’:1, 6]pyrido[3, 4-b]indole-1, 4-dione, 6-(1, 3benzodioxol-5-yl)-2, 3, 6, 7, 12, 12a-hexahydro-2-methyl-, (6R, ADCIRCA® (tadalafil) NAME OF THE MEDICINE ADCIRCA® (tadalafil). Chemically, tadalafil is pyrazino[1’, 2’:1, 6]pyrido[3, 4-b]indole-1, 4-dione, 6-(1, 3benzodioxol-5-yl)-2, 3, 6, 7, 12, 12a-hexahydro-2-methyl-, (6R,](https://www.pdfsearch.io/img/980a34e56bf58ef7970a3587a4af06cb.jpg) | Add to Reading ListSource URL: gp2u.com.auLanguage: English - Date: 2013-08-31 02:43:59
|
---|
3![Briefing Book - April 2010 Briefing Book - April 2010](https://www.pdfsearch.io/img/11a5b2f870356b1b7388ebc413e6ed74.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
4![Caffeine-Containing Botanicals in Dietary Supplements from 2 to 4 cups of coffee, another 11 had equivalents ranging from 4 to 6 cups of coffee, and 4 products provided an amount of caffeine ranging from 7 to 8 cups of c Caffeine-Containing Botanicals in Dietary Supplements from 2 to 4 cups of coffee, another 11 had equivalents ranging from 4 to 6 cups of coffee, and 4 products provided an amount of caffeine ranging from 7 to 8 cups of c](https://www.pdfsearch.io/img/3938a22503f0cdb1bd7f9e89ac598be4.jpg) | Add to Reading ListSource URL: www.ars.usda.govLanguage: English - Date: 2009-03-30 09:06:10
|
---|
5![Docket No. OON[removed]Dockets Management Branch (HFA-305) Food and Drug Administration 5630 Fishers Lane rm[removed]Rockville Docket No. OON[removed]Dockets Management Branch (HFA-305) Food and Drug Administration 5630 Fishers Lane rm[removed]Rockville](https://www.pdfsearch.io/img/e7098f53899475e34ed0464a51951a76.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2000-10-23 04:30:37
|
---|
6![Effects of cAMP-dependent protein kinase activator and inhibitor on in vivo rolipram binding to phosphodiesterase 4 in conscious rats Effects of cAMP-dependent protein kinase activator and inhibitor on in vivo rolipram binding to phosphodiesterase 4 in conscious rats](https://www.pdfsearch.io/img/d09c0d45bb312467a2afc255031e04c7.jpg) | Add to Reading ListSource URL: intramural.nimh.nih.govLanguage: English - Date: 2010-01-04 11:40:27
|
---|
7![Phosphodiesterase 4D is required for 2 adrenoceptor subtype-specific signaling in cardiac myocytes Yang Xiang*†, Fabio Naro†‡§, Maria Zoudilova‡, S.-L. Catherine Jin‡, Marco Conti‡¶, and Brian Kobilka*¶ Phosphodiesterase 4D is required for 2 adrenoceptor subtype-specific signaling in cardiac myocytes Yang Xiang*†, Fabio Naro†‡§, Maria Zoudilova‡, S.-L. Catherine Jin‡, Marco Conti‡¶, and Brian Kobilka*¶](https://www.pdfsearch.io/img/31e753a3ed64f4fefd624a1d3dc49767.jpg) | Add to Reading ListSource URL: med.stanford.eduLanguage: English - Date: 2009-12-04 19:10:48
|
---|
8![Saskatchewan Drug Information Services College of Pharmacy and Nutrition, U of S T: ([removed]F:([removed]www.usask.ca/druginfo Vol. 20, No. 4 Saskatchewan Drug Information Services College of Pharmacy and Nutrition, U of S T: ([removed]F:([removed]www.usask.ca/druginfo Vol. 20, No. 4](https://www.pdfsearch.io/img/a7e12b7605a494d8ca5789e3450682f8.jpg) | Add to Reading ListSource URL: medsask.usask.caLanguage: English - Date: 2013-03-14 12:11:16
|
---|
9![PRIOR AUTHORIZATION POLICY Otezla® (apremilast tablets – Celgene Corporation) To Initiate a Coverage Review, Call[removed]OVERVIEW Otezla, a phosphodiesterase 4 (PDE4) inhibitor, is indicated for treatment of a PRIOR AUTHORIZATION POLICY Otezla® (apremilast tablets – Celgene Corporation) To Initiate a Coverage Review, Call[removed]OVERVIEW Otezla, a phosphodiesterase 4 (PDE4) inhibitor, is indicated for treatment of a](https://www.pdfsearch.io/img/f5b43faf1b3a827554f9cb87a9bc264c.jpg) | Add to Reading ListSource URL: statehealthplan.state.nc.usLanguage: English - Date: 2014-05-29 15:15:36
|
---|
10![CHAPTER 1 AL cAMP-Specific Phosphodiesterases: Modulation, Inhibition, and Activation CHAPTER 1 AL cAMP-Specific Phosphodiesterases: Modulation, Inhibition, and Activation](https://www.pdfsearch.io/img/cf0c57934d4affd6db3e2d4317701e20.jpg) | Add to Reading ListSource URL: media.wiley.comLanguage: English - Date: 2013-08-27 10:18:46
|
---|